NEW YORK, Jan. 29, 2024 /PRNewswire/ — This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the “Fund”) with information regarding the sources of the distribution to be paid on January 31, 2024 and cumulative distributions paid fiscal…
Month: January 2024
NEW YORK, Jan. 29, 2024 /PRNewswire/ — This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the “Fund”) with information regarding the sources of the distribution to be paid on January 31, 2024 and cumulative distributions paid fiscal…
NEW YORK, Jan. 29, 2024 /PRNewswire/ — This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the “Fund”) with information regarding the sources of the distribution to be paid on January 31, 2024 and cumulative distributions paid fiscal…
NEW YORK, Jan. 29, 2024 /PRNewswire/ — This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the “Fund”) with information regarding the sources of the distribution to be paid on January 31, 2024 and cumulative distributions paid fiscal…
NEW YORK, Jan. 29, 2024 /PRNewswire/ — This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the “Fund”) with information regarding the sources of the distribution to be paid on January 31, 2024 and cumulative distributions paid fiscal…
NEW YORK, Jan. 29, 2024 /PRNewswire/ — This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the “Fund”) with information regarding the sources of the distribution to be paid on January 31, 2024 and cumulative distributions paid fiscal…
NEW YORK, Jan. 29, 2024 /PRNewswire/ — The renal anemia therapeutics market is estimated to grow by USD 2.08 billion during 2023-2028, growing at a CAGR of 7.59%. Akebia Therapeutics Inc and Amgen Inc to emerge as some of the major companies. Akebia Therapeutics Inc offers adadustat. The…
NEW YORK, Jan. 29, 2024 /PRNewswire/ — The renal anemia therapeutics market is estimated to grow by USD 2.08 billion during 2023-2028, growing at a CAGR of 7.59%. Akebia Therapeutics Inc and Amgen Inc to emerge as some of the major companies. Akebia Therapeutics Inc offers adadustat. The…
NEW YORK, Jan. 29, 2024 /PRNewswire/ — J. Safra Real Estate (“JSRE”), the real estate arm of The J. Safra Group (the “Group”), announced today that it will acquire Faneuil Hall Marketplace in Boston, Massachusetts. JSRE’s acquisition of this signature property from Ashkenazy Acquisition…
NEW YORK, Jan. 29, 2024 /PRNewswire/ — J. Safra Real Estate (“JSRE”), the real estate arm of The J. Safra Group (the “Group”), announced today that it will acquire Faneuil Hall Marketplace in Boston, Massachusetts. JSRE’s acquisition of this signature property from Ashkenazy Acquisition…
